NKTR-214 in Combination With Nivolumab – lay summary Study of Nivolumab + Ipilimumab Versus Nivolumab Alone – lay summary NCT03055013 lay summary More from the InfoHUB InfoHub (6) Topics (25) Decision aids (1) Factsheets (9) Graphics (2) Guidelines (1) Publications (9) Karin Kastrati2019-11-14T12:28:21+01:00November 14th, 2019|Uncategorised|